CannaPharmaRx (OTCQB:CPMD)

Detailed Quote · Free Stock Analysis

In this CFN interview, Gerry Crocker of CannaPharmaRx comments on his company’s contribution to the legal marijuana industry, why he’s come to the Cannabis World Congress & Business Expo in NYC, and how his company will evolve and capitalize on the industry over the next year.

Gerry Crocker previously served as CEO of Community Specialty Pharmacy Network (CSPN), an organization comprised of more than 200 community-based specialty pharmacies with stores operating in 47 states, Washington DC, and Puerto Rico. CSPN’s member pharmacies are known for being “centers of excellence” in disease management.  CSPN’s network of pharmacies is the nation’s 8th largest specialty pharmacy provider; CSPN serves as the central contracting agent for its members in the specialty provider network arena, pharmaceutical manufacturer rebate initiatives, and in-patient adherence and compliance programs. Previous to CSPN, Gerry was CEO and President of the Board of Directors for CARE Pharmacies, Inc. Gerry was Vice President of Retail and Alternate Care Sales for Cardinal Health East Group prior to his role at CARE Pharmacies. Gerry holds a Business Administration degree from Northern Michigan University in Marquette, MI.

In this CFN interview, Jim Smeeding of CannaPharmaRx comments on cannabinoid-based research, science, data, and evidence of benefits to patients. CannaPharmaRx is a pharmaceutical company who is advancing discovery in cannabinoid-based medicines to help patients prevail over chronic and acute medical conditions. Their mission is to bring cannabinoid-based products to the U.S. market and worldwide.

Jim Smeeding is a founder of the Center for Pharmacoeconomic Studies at the University Of Texas College Of Pharmacy. His research interests are in applied pharmacoeconomics, systems integration and managed care. Over the past 39 years, his practice orientation has been in hospital pharmacy, clinical services design, home infusion therapy, managed care services and disease management. Jim received his pharmacy degree from the University of Buffalo and his MBA degree from the University of Texas.

Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit:

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer